January 15th, 2025 – We are thrilled to announce a pivotal achievement in Pharmatech AI’s history: The construction of our state-of-the-art MDIP Lab Grow Module was completed on schedule in January 2025. This 200 m² cutting-edge research facility combines vertical cannabis cultivation with AI-driven analytics, marking a major leap forward in our mission to revolutionize...
Construction of our MDIP Lab Grow has begun
Our multi-million-euro research center is poised to redefine precision cannabinoid production and cannabis cultivation through its state-of-the-art hybrid cultivation-research facility. By integrating real-time research data directly into cultivation protocols, we can test countless molecular combinations while simultaneously growing new cultivars to validate theoretical models in practice. This groundbreaking investment delivers a globally unique cultivation module...
Why AI-Driven Cannabinoid Research is an Untapped Billion-Dollar Potential
To align our business model for long-term success, we conducted an in-depth market analysis early on, with results that confirmed and accelerated our strategic direction. A five-member research team conducted over 200 in-depth interviews with stakeholders, from pharmacists in Munich to pain specialists in Boston. The findings were clear: 1. High Dissatisfaction with Existing Therapies...